Cellectis S.A., a clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product ...
Leadership
Andre Choulika Ph.D.Founder
Co-Founder, CEO & Director
David J. Sourdive Ph.D.Founder
Co-Founder, Deputy CEO, Executive VP of CMC & Manufacturing and Director
Arthur Stril
CFO & Chief Business Officer
Valerie Cros
Principal Financial Officer & Principal Accounting Officer
Jean Charles Epinat Ph.D.
Chief Technological Officer
Philippe Duchateau Ph.D.
Chief Scientific Officer
Marie-Bleuenn Terrier
General Counsel & Secretary of the Board of Directors
